Tracking global patterns of N-linked glycosylation site variation in highly variable viral glycoproteins: HIV, SIV, and HCV envelopes and influenza hemagglutinin

Glycobiology

Volumn 14, Issue 12, 2004, Pages 1229-1246

  Zhang, Ming ^a   Gaschen, Brian ^a   Blay, Wendy ^b,c   Foley, Brian ^a   Haigwood, Nancy ^b,c   Kuiken, Carla ^a   Korber, Bette ^d  

^a LOS ALAMOS NATIONAL LABORATORY   (United States)

^b SEATTLE BIOMEDICAL RESEARCH INSTITUTE   (United States)

^c UNIVERSITY OF WASHINGTON   (United States)

^d SANTA FE INSTITUTE   (United States)

Author keywords

Immune escape; N linked glycosylation; Neutralization antibody; Variability; Virus

Indexed keywords

INFLUENZA VIRUS HEMAGGLUTININ; VIRUS ENVELOPE PROTEIN; VIRUS GLYCOPROTEIN;

AMINO ACID SEQUENCE; COMPUTER PROGRAM; GENETIC VARIABILITY; HEPATITIS C VIRUS; HUMAN IMMUNODEFICIENCY VIRUS; INFLUENZA VIRUS; INTERNET; NONHUMAN; POINT MUTATION; PRIORITY JOURNAL; PROTEIN GLYCOSYLATION; REVIEW; SEQUENCE ALIGNMENT; SEQUENCE ANALYSIS; SIMIAN IMMUNODEFICIENCY VIRUS;

ANIMALS; BINDING SITES; EVOLUTION, MOLECULAR; GLYCOPROTEINS; GLYCOSYLATION; HEMAGGLUTININ GLYCOPROTEINS, INFLUENZA VIRUS; HEPACIVIRUS; HIV; HIV ENVELOPE PROTEIN GP120; HUMANS; PHENOTYPE; PHYLOGENY; SIMIAN IMMUNODEFICIENCY VIRUS; SPECIES SPECIFICITY; TIME; VARIATION (GENETICS); VIRAL ENVELOPE PROTEINS;

AVES; HEPATITIS C VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 2; INFLUENZA VIRUS; PRIMATES; SIMIAE; SIMIAN IMMUNODEFICIENCY VIRUS;

EID: 9744280420     PISSN: 09596658     EISSN: None     Source Type: Journal    
DOI: 10.1093/glycob/cwh106     Document Type: Review

References (96)

1. Albert, J., Abrahamsson, B., Nagy, K., Aurelius, E., Gaines, H., Nystrom, G., and Fenyo, E.M. (1990) Rapid development of isolate-specific neutralizing antibodies after primary HIV-1 infection and consequent emergence of virus variants which resist neutralization by autologous sera. AIDS, 4, 107-112.
2. Alexander, S. and Elder, J.H. (1984) Carbohydrate dramatically influences immune reactivity of antisera to viral glycoprotein antigens. Science, 226, 1328-1330.
3. Arendrup, M., Nielsen, C., Hansen, J.E., Pedersen, C., Mathiesen, L., and Nielsen, J.O. (1992) Autologous HIV-1 neutralizing antibodies: emergence of neutralization-resistant escape virus and subsequent development of escape virus neutralizing antibodies. J. AIDS, 5, 303-307.
4. Bolmstedt, A., Sjolander, S., Hansen, J.E., Akerblom, L., Hemming, A., Hu, S.L., Morein, B., and Olofsson, S. (1996) Influence of N-linked glycans in V4-V5 region of human immunodeficiency virus type 1 glycoprotein gp160 on induction of a virus-neutralizing humoral response. J. AIDS Hum. Retrovirol., 12, 213-220.
5. Bosch, M.L., Andeweg, A.C., Schipper, R., and Kenter, M. (1994) Insertion of N-linked glycosylation sites in the variable regions of the human immunodeficiency virus type 1 surface glycoprotein through AAT triplet reiteration. J. Virol., 68, 7566-7569.
6. Botarelli, P., Houlden, B.A., Haigwood, N.L., Servis, C., Montagna, D., and Abrignani, S. (1991) N-glycosylation of HIV-gp12O may constrain recognition by T lymphocytes. J. Immunol., 147, 3128-3132.
7. Bradney, A.P., Scheer, S., Crawford, J.M., Buchbinder, S.P., and Montefiori, D.C. (1999) Neutralization escape in human immunodeficiency virus type 1-infected long-term nonprogressors. J. Infect. Dis., 179, 1264-1267.
8. Broussard, S.R., Staprans, S.I., White, R., Whitehead, E.M., Feinberg, M.B., and Allan, J.S. (2001) Simian immunodeficiency virus replicates to high levels in naturally infected African green monkeys without inducing immunologic or neurologic disease. J. Virol., 75, 2262-2275.
9. Bush, R.M., Fitch, W.M., Bender, C.A., and Cox, N.J. (1999) Positive selection on the H3 hemagglutinin gene of human influenza virus A. Mol. Biol. Evol., 16, 1457-1465.
10. Chackerian, B., Morton, W.R., and Overbaugh, J. (1994) Persistence of simian immunodeficiency virus Mne variants upon transmission. J. Virol., 68, 4080-4085.
11. Chackerian, B., Rudensey, L.M., and Overbaugh, J. (1997) Specific N-linked and O-linked glycosylation modifications in the envelope V1 domain of simian immunodeficiency virus variants that evolve in the host alter recognition by neutralizing antibodies. J. Virol. 71, 7719-7727.
12. Cheng-Mayer, C., Brown, A., Harouse, J., Luciw, P.A., and Mayer, A.J. (1999) Selection for neutralization resistance of the simian/human immunodeficiency virus SHIVSF33A variant in vivo by virtue of sequence changes in the extracellular envelope glycoprotein that modify N-linked glycosylation. J. Virol., 73, 5294-5300.
13. Cho, M.W., Lee, M.K., Carney, M.C., Berson, J.F., Doms, R.W., and Martin, M.A. (1998) Identification of determinants on a dualtropic human immunodeficiency virus type 1 envelope glycoprotein that confer usage of CXCR4. J. Virol., 72, 2509-2515.
14. Clark, G.F., Dell, A., Morris, H.R., Patankar, M., Oehninger,S., and Seppala, M. (1997) Viewing AIDS from a glycobiological perspective: potential linkages to the human fetoembryonic defence system hypothesis. Mol. Hum. Reprod., 3, 5-13.
15. Cleveland, S.M., McLain, L., Cheung, L., Jones, T.D., Hollier, M., and Dimmock, N.J. (2003) A region of the C-terminal tail of the gp41 envelope glycoprotein of human immunodeficiency virus type 1 contains a neutralizing epitope: evidence for its exposure on the surface of the virion. J. Gen. Virol., 84, 591-602.
16. Davis, D., Stephens, D.M., Willers, C., and Lachmann, P.J. (1990) Glycosylation governs the binding of antipeptide antibodies to regions of hypervariable amino acid sequence within recombinant gp120 of human immunodeficiency virus type 1. J. Gen. Virol., 71(12 , 2889-2898.
17. Deleersnyder, J., Pillez, A., Wychowski, C., Blight, K., Xu, J., Hahn, Y.S., Rice, C.M., and Dubuission, J. (1997) Formation of native hepatitis C virus glycoprotein complexes. J. Virol., 71, 697-704.
18. Delwart, E.L., Pan, H., Sheppard, H.W., Wolpert, D., Neumann, A.U., Korber, B., and Mullins, J.I. (1997) Slower evolution of human immunodeficiency virus type 1 quasispecies during progression to AIDS. J. Virol., 71, 7498-7508.
19. Dubuisson, J., Duvet, S., Meunier, J.C., De Beeck, O., Cacan, R., Wychowski, C., and Cocquerel, L. (2000) Glycosylation of the hepatitis C virus envelope protein E1 is dependent on the presence of a downstream sequence on the viral polyprotein. J. Biol. Chem., 275, 30605-30609.
20. Ferguson, N.M., Galvani, A.P., and Bush, R.M. (2003) Ecological and immunological determinants of influenza evolution. Nature, 422, 428-433.
21. Ferris, R.L., Hall, C., Sipsas, N.V., Safrit, J.T., Trocha, A., Koup, R.A., Johnson, R.P., and Siliciano, R.F. (1999) Processing of HIV-1 envelope glycoprotein for class I-restricted recognition: dependence on TAP1/2 and mechanisms for cytosolic localization. J. Immunol., 162, 1324-1332.
22. Fournillier, A., Wychowski, C., Boucreux, D., Baumert, T.F., Meunier, J.C., Jacobs, D., Muguet, S., Depla, E., and Inchauspe, G. (2001) Induction of hepatitis C virus E1 envelope protein-specific immune response can be enhanced by mutation of N-glycosylation sites. J. Virol., 75, 12088-12097.
23. Fultz, P.N., Stricker, R.B., McClure, H.M., Anderson, D.C., Switzer, W.M., and Horaist, C. (1990) Humoral response to SIV/SMM infection in macaque and mangabey monkeys. J. AIDS, 3, 319-329.
24. Gao, F., Morrison, S.G., Robertson, D.L., Thornton, C.L., Craig, S., Karlsson, G., Sodroski, J., Morgado, M., Galvao-Castro, B., von Briesen, H. and others. (1996) Molecular cloning and analysis of functional envelope genes from human immunodeficiency virus type 1 sequence subtypes A through G. The WHO and NIAID networks for HIV isolation and characterization. J. Virol., 70, 1651-1667.
25. Gavel, Y. and von Heijne, G. (1990) Sequence differences between glycosylated and non-glycosylated Asn-X-Thr/Ser acceptor sites: implications for protein engineering. Protein Eng., 3, 433-442.
26. Gicheru, M.M., Otsyula, M., Spearman, P., Graham, B.S., Miller, C.J., Robinson, H.L., Haigwood, N.L., and Montefiori, D.C. (1999) Neutralizing antibody responses in Africa green monkeys naturally infected with simian immunodeficiency virus (SIVagm). J. Med. Primatol., 28, 97-104.
27. Gram, G.J., Bolmstead, A., Schonning, K., Biller, M., Hansen, J.E., Olofasson, S. (2002) Detection of orientation-specific anti-gp120 antibodies by a new N-glycanase protection assay. APMIS, 110, 123-31.
28. Hebert, D.N., Zhang, J.X., Chen, W., Foellmer, B., and Helenius, A. (1997) The number and location of glycans on influenza hemagglutinin determine folding and association with calnexin and calreticulin. J. Cell Bio., 139, 613-623.
29. Hirsch, V.M., Olmsted, R.A., Murphey-Corb, M., Purcell, R.H., and Johnson, P.R. (1989) An African primate lentivirus (SIVsm) closely related to HIV-2. Nature, 339, 389-392.
30. Hoffman, T.L., Stephens, E.B., Narayan, O., and Doms, R.W. (1998) HIV type I envelope determinants for use of the CCR2b, CCR3, STRL33, and APJ coreceptors. Proc. Natl Acad. Sci. USA, 95, 11360-11365.
31. Hu, Q.X., Barry, A.P., Wang, Z.X., Connolly, S.M., Peiper, S.C., and Greenberg, M.L. (2000) Evolution of the human immunodeficiency virus type 1 envelope during infection reveals molecular corollaries of specificity for coreceptor itilization and AIDS pathogenesis. J. Virol., 74, 11858-11872.
32. Kalish, M.L., Korber, B.T., Pillai, S., Robbins, K.E., Leo, Y.S., Saekhou, A., Verghese, I., Gerrish, P., Goh, C.L., Lupo, D., Tan, B.H., Brown, T.M., and Chan, R. (2002) The sequential introduction of HIV-1 subtype B and CRF01AE in Singapore by sexual transmission: accelerated V3 region evolution in a subpopulation of Asian CRF01 viruses. Virology, 304, 311-329.
33. Kasturi, L., Eshleman, J.R., Wunner, W.H., and Shakin-Eshleman, S.H. (1995) The hydroxy amino acid in an Asn-X-Ser/Thr sequon can influence N-linked core glycosylation efficiency and the level of expression of a cell surface glycoprotein. J. Biol. Chem., 270, 14756-14761.
34. Kaur, A., Grant, R.M., Means, R.E., McClure, H., Feinberg, M., and Johnson, R.P. (1998) Diverse host responses and outcomes following simian immunodeficiency virus SIVmac239 infection in sooty mangabeys and Rhesus macaques. J. Virol., 72, 9597-9611.
35. Kaur, A., Alexander, L., Staprans, S.I., Denekamp, L., Hale, C.L., McClure, H.M., Feinberg, M.B., Desrosiers, R.C., and Johnson, R.P. (2001) Emergence of cytotoxic T lymphocyte escape mutations in nonpathogenic simian immunodeficiency virus infection. Eur. J. Immunol., 31, 3207-3217.
36. Kaverin, N.V., Rudneva, I.A., Ilyushina, N.A., Varich, N.L., Lipatov, A.S., Smirnov, Y.A., Govorkova, E.A., Gitelman, A.K., Lvov, D.K., and Webster, R.G. (2002) Structure of antigenic sites on the haemagglutinin molecule of H5 avian influenza virus and phenotypic variation of escape mutants. J. Gen. Virol., 83, 2497-2505.
37. Koito, A., Stamatatos, L., and Cheng-Mayer, C. (1995) Small amino acid sequence changes within the V2 domain can affect the function of a T-cell line-tropic human immunodeficiency virus type 1 envelope gp120. Virology, 206, 878-884.
38. Korber, B., Muldoon, M., Theiler, J., Gao, F., Gupta, R., Lapedes, A., Hahn, B.H., Wolinsky, S., and Bhattacharya, T. (2000) Timing the ancestor of the HIV-1 pandemic strains. Science, 288, 1789-1796.
39. Korber, B., Gaschen, B., Yusim, K., Thakallapally, R., Kesmir, C., and Detours, V. (2001) Evolutionary and immunological implications of gontemporary HIV-1 variation. Br. Med. Bull., 58 19-42.
40. Kottilil, S., Chun, T.W., Moir, S., Liu, S., McLaughlin, M., Hallahan, C.W., Maldarelli, F., Corey, L., and Fauci, A.S. (2003) Innate immunity in human immunodeficiency virus infection: effect of viremia on natural killer cell function. J. Infect. Dis., 187, 1038-1045.
41. Kuiken, C., Foley, B., Guzman E., and Korber, B. (1999) Determinants of HIV-1 protein evolution. In Crandall, K. (Ed.), Molecular evolution of HIV. Johns Hopkins University Press, Baltimore, MD.
42. Land, A. and Braakman, I. (2001) Folding of the human immunodeficiency virus type 1 envelope glycoprotein in the endoplasmic reticulum. Biochimie, 83, 783-790.
43. Leonard, C.K., Spellman, M.W., Riddle, L., Harris, R.J., Thomas, J.N., and Gregory, T.J. (1990) Assignment of intrachain disulfide bonds and characterization of potential glycosylation sites of the type 1 recombinant human immunodeficiency virus envelope glycoprotein (gp120) expressed in Chinese hamster ovary cells. J. Biol. Chem., 265 10373-10382.
44. Liedtke, S., Geyer,R., and Geyer, H. (1997) Host-cell-specific glycosylation of HIV-2 envelope glycoprotein. Glycoconj. J., 14, 785-793.
45. Lin, G., Simmons, G., Pohlmann, S., Baribaud, F., Ni, H., Leslie, G.J., Haggarty, B.S., Bates, P., Weissman, D., Hoxie, J.A., and Doms, R.W. (2003) Differential N-linked glycosylation of human immunodeficiency virus and Ebola virus envelope glycoproteins modulates interactions with DC-SIGN and DC-SIGNR. J. Virol., 77, 1337-1346.
46. Losman, B., Bolmstedt, A., Schonning, K., Bjorndal, A., Westin, C., Fenyo, E.M., and Olofsson, S. (2001) Protection of neutralization epitopes in the V3 loop of oligomeric human immunodeficiency virus type 1 glycoprotein 120 by N-linked oligosaccharides in the V1 region. AIDS Res. Hum. Retroviruses, 17, 1067-1076.
47. Ly, A. and Stamatatos, L. (2000) V2 loop glycosylation of the human immunodeficiency virus type 1 SF162 envelope facilitates interaction of this protein with CD4 and CCR5 receptors and protects the virus from neutralization by anti-V3 loop and anti-CD4 binding site antibodies. J. Virol., 74, 6769-6776.
48. Malenbaum, S.E., Yang, D., Cavacini, L., Posner, M., Robinson, J., and Cheng-Mayer, C. (2000) The N-terminal V3 loop glycan modulates the interaction of clade A and B human immunodeficiency virus type 1 envelopes with CD4 and chemokine receptors. J. Virol., 74, 11008-11016.
49. Marshall, R.D. (1974) The nature and metabolism of the carbohydrate-peptide linkages of glycoproteins. Biochem. Soc. Symp. 17-26.
50. Masciotra, S., Owen, S.M., Rudolph, D., Yang, C., Wang, B., Saksena, N., Spira, T., Dhawan, S., and Lal, R.B. (2002) Temporal relationship between V1V2 variation, macrophage replication, and coreceptor adaptation during HIV-1 disease progression. AIDS, 16 1887-1898.
51. Matrosovich, M., Zhou, N., Kawaoka, Y., and Webster, R. (1999) The surface glycoproteins of H5 influenza viruses isolated from humans, chickens, and wild aquatic birds have distinguishable properties. J. Virol., 73, 1146-1155.
52. Matthews, T.J., Weinhold, K.J., Lyerly, H.K., Langlois, A.J., Wigzell, H., and Bolognesi, D.P. (1987) Interaction between the human T-cell lymphotropic virus type IIIB envelope glycoprotein gp120 and the surface antigen CD4: role of carbohydrate in binding and cell fusion. Proc. Natl Acad. Sci. USA, 84, 5424-5428.
53. Mellquist, J.L., Kasturi, L., Spitalnik, S.L., and Shakin-Eshleman, S.H. (1998) The amino acid following an Asn-X-Ser/Thr sequon is an important determinant of N-linked core glycosylation efficiency. Biochemistry, 37, 6833-6837.
54. Meunier, J.C., Fournillier, A., Choukhi, A., Cahour, A., Cocquerel, L., Dubuisson, J., and Wychowski, C. (1999b) Analysis of the glycosylation sites of hepatitis C virus (HCV) glycoprotein E1 and the influence of E1 glycans on the formation of the HCV glycoprotein complex. J. Gen. Virol., 80(4), 887-896.
55. Mizuochi, T., Spellman, M.W., Larkin, M., Solomon, J., Basa, L.J., and Feizi, T. (1988) Carbohydrate structures of the human-immunodeficiency-virus (HIV) recombinant envelope glycoprotein gp120 produced in Chinese-hamster ovary cells. Biochem. J., 254 599-603.
56. Mizuochi, T., Matthews, T.J., Kato, M., Hamako, J., Titani, K., Solomon, J., and Feizi, T. (1990) Diversity of oligosaccharide structures on the envelope gycoprotein gp 120 of human immunodeficiency virus 1 from the lymphoblastoid cell line H9. Presence of complex-type oligosaccharides with bisecting N-acetylglucosamine residues. J. Biol. Chem., 265, 8519-8524.
57. Montefiori, D.C., Zhou, I.Y., Barnes, B., Lake, D., Hersh, E.M., Masuho, Y., and Lefkowitz, L.B. Jr. (1991) Homotypic antibody responses to fresh clinical isolates of human immunodeficiency virus. Virology, 182, 635-643.
58. Moore, J.P. and Sodroski, J. (1996) Antibody cross-competition analysis of the human immunodeficiency virus type 1 gp120 exterior envelope glycoprotein. J. Virol., 70, 1863-1872.
59. Myers, G., MacInnes, K., and Korber, B. (1992) The emergence of simian/human immunodeficiency viruses. AIDS Res. Hum. Retroviruses 8, 373-386.
60. Norley, S.G., Kraus, G., Ennen, J., Bonilla, J., Konig, H., and Kurth, R. (1990) Immunological studies of the basis for the apathogenicity of simian immunodeficiency virus from African green monkeys. Proc. Natl Acad. Sci. USA, 87, 9067-9071.
61. Norley, S., Beer, B., Holzammer, S., zur Megede, J., and Kurth, R. (1999) Why are the natural hosts of SIV resistant to AIDS? Immunol. Lett., 66, 47-52.
62. Nyambi, P.N., Lewi, P., Peeters, M., Janssens, W., Heyndrickx, L., Fransen, K., Andries, K., Vanden Haesevelde, M., Heeney, J., Piot, P., and van der Groen, G. (1997) Study of the dynamics of neutralization escape mutants in a chimpanzee naturally infected with the simian immunodeficiency virus SIVcpz-Ant. J. Virol., 71, 2320-2330.
63. Ogert, R.A., Lee, M.K., Ross, W., Buckler-White, A., Martin, M.A., and Cho, M.W. (2001) N-linked glycosylation sites adjacent to and within the V1/V2 and the V3 loops of dualtropic human immunodeficiency virus type 1 isolate DH12 gp120 affect coreceptor usage and cellular tropism. J. Virol., 75, 5998-6006.
64. Ohgimoto, S., Shioda, T., Mori, K., Nakayama, E.E., Hu, H., and Nagai, Y. (1998) Location-specific, unequal contribution of the N glycans in simian immunodeficiency virus gp120 to viral infectivity and removal of multiple glycans without disturbing infectivity. J. Virol. 72, 8365-8370.
65. Ohta, Y., Masuda, T., Tsujimoto, H., Ishikawa, K., Kodama, T., Morikawa, S., Nakai, M., Honjo, S., and Hayami, M. (1988) Isolation of simian immunodeficiency virus from African green monkeys and seroepidemiologic survey of the virus in various non-human primates. Int. J. Cancer, 41, 115-122.
66. Overbaugh, J. and Rudensey, L.M. (1992) Alterations in potential sites for glycosylation predominate during evolution of the simian immunodeficiency virus envelope gene in macaques. J. Virol., 66, 5937-5948.
67. Overbaugh, J., Rudensey, L.M., Papenhausen, M.D., Benveniste, R.E., and Morton, W.R. (1991) Variation in simian immunodeficiency virus Env is confined to V1 and V4 during progression to simian AIDS. J. Virol., 65, 7025-7031.
68. Pollakis, G., S., Kang, Kliphuis, A., Chalaby, M.I., Goudsmit, J., and Paxton, W.A. (2001) N-linked glycosylation of the HIV type-1 gp120 envelope glycoprotein as a major determinant of CCR5 and CXCR4 coreceptor utilization. J. Biol. Chem., 276, 13433-13441.
69. Polonoff, E., Machida, C.A., and Kabat, D. (1982) Glycosylation and intracellular transport of membrane glycoproteins encoded by murine leukemia viruses. Inhibition by amino acid analogues and by tunicamycin. J. Biol. Chem., 257, 14023-14028.
70. Ratner, L. (1992) Glucosidase inhibitors for treatment of HIV-1 infection. AIDS Res. Hum. Retroviruses, 8, 165-173.
71. Rice, C.M. (1996) Flaviviridae: the viruses and their replication. In Fields, B.N., Knipe, D.M., and Howley, P.M. (Eds.), Field's virology, Lippincott-Raven Philidelphia, pp. 931-959.
72. Richman, D.D., Wrin, T., Little, S.J., and Petropoulos, C.J. (2003) Rapid evolution of the neutralizing antibody response to HIV type 1 infection. Proc. Natl Acad. Sci. USA, 100, 4144-4149.
73. Robbins, K.E., Lemey, P., Pybus, O.G., Jaffe, H.W., Youngpairoj, A.S., Brown, T.M., Salemi, M., Vandamme, A.M., and Kalish, M.L. (2003) U.S. human immunodeficiency virus type 1 epidemic: date of origin, population history, and characterization of early strains. J. Virol., 77, 6359-6366.
74. Robertson, D.L., Anderson, J.P., Bradac, J.A., Carr, J.K., Foley, B., Funkhouser, R.K., Gao, F., Hahn, B.H., Kalish, M.L., Kuiken, C., and others. (2000) HIV-1 nomenclature proposal. Science, 288 55-56.
75. Sanders, R.W., Venturi, M., Schiffner, L., Kalyanaraman, R., Katinger, H., Lloyd, K.O., Kwong, P.D., and Moore, J.P. (2002) The mannose-dependent epitope for neutralizing antibody 2G12 on human immunodeficiency virus type 1 glycoprotein gp120. J. Virol., 76 7293-7305.
76. Sato, K., Okamoto, H., Aihara, S., Hoshi, Y., Tanaka, T., and Mishiro, S. (1993) Demonstration of sugar moiety on the surface of hepatitis C virions recovered from the circulation of infected humans. Virology, 196, 354-357.
77. Scanlan, C.N., Pantophlet, R., Wormald, M.R., Ollmann, S.E., Stanfield, R., Wilson, I.A., Katinger, H., Dwek, R.A., Rudd, P.M., and Burton, D.R. (2002) The broadly neutralizing anti-human immunodeficiency virus type 1 antibody 2G12 recognizes a cluster of alpha 1 → 2 mannose residues on the outer face of gp120. J. Virol., 76, 7306-7321.
78. Selby, M., Erickson, A., Dong, C., Cooper, S., Parham, P., Houghton, M., and Walker, C.M. (1999) Hepatitis C virus envelope glycoprotein E1 originates in the endoplasmic reticulum and requires cytoplasmic processing for presentation by class I MHC molecules. J. Immunol., 162, 669-676.
79. Shakin-Eshleman, S.H., Spitalnik, S.L., and Kasturi, L. (1996) The amino acid at the X position of an Asn-X-Ser sequon is an important determinant of N-linked core-glycosylation efficiency. J. Biol. Chem., 271, 6363-6366.
80. Shioda, T., Oka, S., Xin, X., Liu, H., Harukuni, R., Kurotani, A., Fukushima, M., Hasan, M.K., Shiino, T., Takebe, Y. and others. (1997) In vivo sequence variability of human immunodeficiency virus type 1 envelope gp120: association of V2 extension with slow disease progression. J. Virol., 71, 4871-4881.
81. Si, Z., Cayabyab, M., and Sodroski, J. (2001) Envelope glycoprotein determinants of neutralization resistance in a simian-human immunodeficiency virus (SHIV-HXBc2P 3.2) derived by passage in monkeys. J. Virol., 75, 4208-4218.
82. Simmonds, P., Zhang, L.Q., McOmish, F., Balfe, P., Ludlam, C.A., and Brown, A.J. (1991) Discontinuous sequence change of human immunodeficiency virus (HIV) type 1 Env sequences in plasma viral and lymphocyte-associated proviral populations in vivo: implications for models of HIV pathogenesis. J. Virol., 65, 6266-6276.
83. Skehel, J.J. and Wiley, D.C. (2000) Receptor binding and membrane fusion in virus entry: the influenza hemagglutinin. Annu. Rev. Biochem., 69, 531-569.
84. Slater-Handshy, T., Droll, D.A., Fan, X., Di Bisceglie, A.M., and Chambers, T.J. (2004) HCV E2 glycoprotein: mutagenesis of N linked glycosylation sites and its effects on E2 expression and processing. Virology, 319, 36-48.
85. Webby, R.J. and Webster, R.G. (2001) Emergence of influenza A viruses. Phil. Trans. R. Soc. Lond B Biol. Sci., 356, 1817-1828.
86. Wei, X., Decker, J.M., Wang, S., Hui, H., Kappes, J.C., Wu, X., Salazar-Gonzalez, J.F., Salazar, M.G., Kilby, J.M., Saag, M.S., Komarova, N.L., Nowak, M.A., Hahn, B.H., Kwong, P.D., Shaw, G. (2003) Antibody neutralization and escape by HIV-1. Nature, 422, 307-312.
87. Wiley, D.C. and Skehel, J.J. (1987) The structure and function of the hemagglutinin membrane glycoprotein of influenza virus. Annu. Rev. Biochem., 56, 365-394.
88. Willey, R.L., Shibata, R., Freed, E.O., Cho, M.W., and Martin, M.A. (1996) Differential glycosylation, virion incorporation, and sensitivity to neutralizing antibodies of human immunodeficiency virus type 1 envelope produced from infected primary T-lymphocyte and macrophage cultures. J. Virol., 70, 6431-6436.
89. Wills, C., Farmer, A., and Myers, G. (1996) Rapid sequon evolution in human immunodeficiency virus type 1 relative to human immunodeficiency virus type 2. AIDS Res. Hum. Retroviruses, 12 1383-1384.
90. Wolinsky, S.M., Wike, C.M., Korber, B.T., Hutto, C., Parks, W.P., Rosenblum, L.L., Kunstman, K.J., Furtado, M.R., and Munoz, J.L. (1992) Selective transmission of human immunodeficiency virus type-1 variants from mothers to infants. Science, 255, 1134-1137.
91. Wolinsky, S.M., Korber, B.T., Neumann, A.U., Daniels, M., Kunstman, K.J., Whetsell, A.J., Furtado, M.R., Cao, Y., Ho, D.D., and Safrit, J.T. (1996) Adaptive evolution of human immunodeficiency virus-type 1 during the natural course of infection. Science, 272, 537-542.
92. Wyatt, R. and Sodroski, J. (1998) The HIV-1 envelope glycoproteins: fusogens, antigens, and immunogens. Science, 280 1884-1888.
93. Ye, Y., Si, Z.H., Moore, J.P., and Sodroski, J. (2000) Association of structural changes in the V2 and V3 loops of the gp120 envelope glycoprotein with acquisition of neutralization resistance in a simian-human immunodeficiency virus passaged in vivo. J. Virol., 74, 11955-11962.
94. Yoshimura, M., Ihara, Y., Ohnishi, A., Ijuhin, N., Nishiura, T., Kanakura, Y., Matsuzawa, Y., and Taniguchi, N. (1996) Bisecting N acetylglucosamine on K562 cells suppresses natural killer cytotoxicity and promotes spleen colonization. Cancer Res., 56, 412-418.
95. Yusim, K., Peeters, M., Pybus, O.G., Bhattacharya, T., Delaporte, E., Mulanga, C., Muldoon, M., Theiler, J., and Korber, B. (2001) Using human immunodeficiency virus type 1 sequences to infer historical features of the acquired immune deficiency syndrome epidemic and human immunodeficiency virus evolution. Phil. Trans. R. Soc. Lond. B Biol. Sci., 356, 855-866.
96. Zhu, X., Borchers, C., Bienstock, R.J., and Tomer, K.B. (2000) Mass spectrometric characterization of the glycosylation pattern of HIV-gp12O expressed in CHO cells. Biochemistry, 39, 11194-11204.